Lilly(Eli) & Co (LLY)

Top Research Reports for Microsoft, Eli Lilly & Costco - Yahoo Finance

Yahoo Finance

EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga

Benzinga

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control - Yahoo Finance

Yahoo Finance

Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates

Zacks Investment Research

Evaluating Eli Lilly and Co Against Peers In Pharmaceuticals Industry - Eli Lilly and Co (NYSE:LLY) - Benzinga

Benzinga

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Zacks Investment Research

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Atai, Eli Lilly, Novartis & more—Chutes & Ladders - Fierce Biotech

Fierce Biotech

Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk - The Motley Fool

The Motley Fool

Eli Lilly's efsitora alfa shows promise in Phase III T2D trials - Clinical Trials Arena

Clinical Trials Arena

Eli Lilly's efsitora alfa shows promise in Phase III T2D trials - Clinical Trials Arena

Clinical Trials Arena

Eli Lilly's efsitora alfa shows promise in Phase III T2D trials - Yahoo Finance

Yahoo Finance

Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs - Yahoo Finance

Yahoo Finance

DB says Roche could challenge obesity drug leaders Eli Lilly, Novo Nordisk - XM

XM

3 Stocks to Buy Following Positive Earnings Results

Zacks Investment Research

Eli Lilly says its experimental weekly insulin works just as well as daily doses - Quartz

Quartz

Eli Lilly falls on a rival's obesity study — plus, we're removing 3 stocks from our watchlist - CNBC

CNBC

Eli Lilly has a great global portfolio and is catching our eyes: Brandon Pizzurro - Fox Business

Fox Business

Eli Lilly says its experimental weekly insulin works just as well as daily doses - Quartz

Quartz

Another quarter of growth in biopharma, with Eli Lilly on top - FiercePharma

FiercePharma

Lilly Oncology ASCO Investor Event | Eli Lilly and Company - Investors | Eli Lilly and Company

Investors | Eli Lilly and Company

Could this pharmaceutical company reach a trillion-dollar valuation? - Finbold - Finance in Bold

Finbold - Finance in Bold

Lilly’s Weekly Insulin Scores Late-Stage Win as Race With Novo Heats Up - BioSpace

BioSpace

Eli Lilly: Weekly Insulin Dose On Par With Common Daily Doses - Eli Lilly and Co (NYSE:LLY) - Benzinga

Benzinga

Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity - Barron's

Barron's

Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data

Zacks Investment Research

Lilly's weekly insulin as effective as daily doses in studies - PharmaLive

PharmaLive

Lilly's weekly insulin as effective as daily doses in studies - Reuters

Reuters

These 2 No-Brainer Growth Stocks Are Breaking New Ground

The Motley Fool

Lilly's Once-Weekly Insulin Top-Line Results Show Benefit - Medscape

Medscape

With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin ... - Investors | Eli Lilly and Company

Investors | Eli Lilly and Company

Lilly keeps on Novo's tail by reporting weekly insulin hits primary endpoint in 2 pivotal trials - Fierce Biotech

Fierce Biotech

Eli Lilly and Company (NYSE:LLY) Price Target Increased to $840.00 by Analysts at Argus - Defense World

Defense World

Duquesne Family Office top Q1 buys, cuts: Coherent, Eli Lilly, others (NYSE:COHR) - Seeking Alpha

Seeking Alpha

Weight loss drug pill is needed to end shortages, Eli Lilly exec says - Quartz

Quartz

Eli Lilly In-House Atty To Retire; New Compliance Chief Sought - Law360

Law360

Eli Lilly expands U.S. Olympic team sponsorship ahead of 2024 Paris games - MM+M Online

MM+M Online

Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector

Zacks Investment Research

Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound - Yahoo Finance

Yahoo Finance

Eli Lilly settles with spa selling knockoff Mounjaro, Zepbound amid crackdown on fake GLP-1 meds - FiercePharma

FiercePharma

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?

Zacks Investment Research

Eli Lilly Takes Legal Action Against Counterfeit Drugs - Finimize

Finimize

Is Lilly Stock A Buy Or A Sell With A Key Alzheimer's Meeting Looming? - Investor's Business Daily

Investor's Business Daily

How Are Eli Lilly's Profit Margins Trending? - Forbes

Forbes

Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies

Zacks Investment Research

Pfizer: Best Trading Momentum Since 2021 And 6% Yield

Seeking Alpha

These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now - The Motley Fool

The Motley Fool

Weight loss drug pill is needed to end shortages, Eli Lilly exec says - Quartz

Quartz

Eli Lilly settles counterfeit versions of its popular diabetes drug - The Financial Express

The Financial Express

Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs - Reuters

Reuters